Agomab Therapeutics NV Adrs (AGMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AGMB | OVID | ANL | ||
| Company | Agomab Therapeutics NV Adrs | Ovid Therapeutics Inc | Adlai Nortye Ltd ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 12.01 | 2.31 | 10.77 | ||
| High | 13.77 | 2.53 | 11.29 | ||
| Low | 12.00 | 2.29 | 10.30 | ||
| Latest | 12.68 | 2.50 | 10.99 | ||
| Change | +0.74 | +0.18 | +0.39 | ||
| % Change | +6.20% | +7.76% | +3.68% | ||
| Volume | 199,300 | 2,805,100 | 25,600 | ||
| 20-Day Average Volume | 110,080 | 2,671,780 | 114,760 | ||
| Previous Close | 11.94 | 2.32 | 10.60 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 10.95 | 2.40 | 10.79 | ||
| 20-Day Raw Stochastic | 78.29% | 55.59% | 42.21% | ||
| 20-Day Relative Strength | 59.23 | 51.74 | 48.74 | ||
| Weighted Alpha | N/A | +153.72 | +24.82 | ||
| Today's Opinion | N/A | 56% Buy | 56% Buy | ||
| Previous Opinion | N/A | 40% Buy | 24% Buy | ||
| Last Month's Opinion | N/A | 56% Buy | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +26.80% since 06/16/26 | +5.93% since 06/16/26 | +9.35% since 06/16/26 | ||
| Low | 9.85 on 06/17/26 | 2.19 on 06/23/26 | 9.89 on 06/18/26 | ||
| High | 13.77 on 06/24/26 | 2.53 on 06/24/26 | 11.80 on 06/22/26 | ||
| 1-Month | |||||
| %Chg | +10.26% since 05/22/26 | +1.21% since 05/22/26 | -7.80% since 05/22/26 | ||
| Low | 8.75 on 06/08/26 | 2.16 on 06/11/26 | 9.46 on 06/08/26 | ||
| High | 13.77 on 06/24/26 | 2.77 on 05/29/26 | 13.08 on 06/01/26 | ||
| 3-Month | |||||
| %Chg | +8.89% since 03/24/26 | +3.31% since 03/24/26 | +57.22% since 03/24/26 | ||
| Low | 8.75 on 06/08/26 | 2.02 on 03/30/26 | 6.34 on 03/30/26 | ||
| High | 13.77 on 06/24/26 | 3.11 on 04/09/26 | 17.25 on 04/21/26 | ||
| 6-Month | |||||
| %Chg | N/A since 02/06/26 | +40.45% since 12/24/25 | +618.30% since 12/24/25 | ||
| Low | 8.75 on 06/08/26 | 1.36 on 02/17/26 | 1.17 on 12/29/25 | ||
| High | 17.45 on 03/03/26 | 3.11 on 04/09/26 | 17.25 on 04/21/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 432,670 | 433,005 | 424,000 | ||
| Shares Outstanding, K | 36,237 | 186,640 | 40,000 | ||
| Annual Sales | 0 | 7,250,000 | 5,000,000 | ||
| Annual Net Income | -70,770,000 | -17,410,000 | -35,530,000 | ||
| Last Quarter Sales | 0 | 720,000 | 0 | ||
| Last Quarter Net Income | -17,401,000 | 9,660,000 | -63,397,000 | ||
| 60-Month Beta | N/A | 0.16 | 0.93 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.12 on 05/12/26 | N/A on 09/29/23 | ||
| Earnings Date | 07/23/26 | 08/12/26 | 04/29/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||